Evidence map›Paper›PMID 41863581›Full record

ArticleBreast cancer research and treatment2026

House value as an individual socioeconomic indicator for breast cancer survival and late-stage diagnosis: a population-based cohort study from Northern Ireland.

Sarah M Baxter, Charlene M McShane, Stuart A McIntosh, Damien Bennett, Meenakshi Sharma, Lynne Lohfeld, Daniel R S Middleton, Gerard Savage, Deirdre Fitzpatrick, Ann McBrien and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast cancer research and treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sarah M BaxterCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK. S.Baxter@qub.ac.uk.
Charlene M McShaneCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
Stuart A McIntoshThe Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, Northern Ireland, UK.
Damien BennettCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
Meenakshi SharmaCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
Lynne LohfeldCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
Daniel R S MiddletonCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
Gerard SavageNorthern Ireland Cancer Registry, Belfast, UK.
Deirdre FitzpatrickNorthern Ireland Cancer Registry, Belfast, UK.
Ann McBrienPatient Representative, Northern Ireland, UK.
David McCallionPatient Representative, England, UK.
Anna GavinCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.
Chris R CardwellCentre for Public Health, Queen's University Belfast, Belfast, Northern Ireland, UK.

Funding

Breast Cancer Now 2023FebIFS1610
6 · The paper itself

Abstract

purposeSocioeconomic inequalities in breast cancer survival persist in the UK. Area-based deprivation measures may underestimate socioeconomic effects by assigning average deprivation levels to all area inhabitants. This study investigated associations between house value (individual-level) and area-based deprivation with breast cancer outcomes in Northern Ireland.

methodsWomen diagnosed with breast cancer from 2011 to 2021 were identified using the Northern Ireland Cancer Registry. House value was determined from Valuation and Lands Agency property valuation data, and area-based deprivation from the Northern Ireland Multiple Deprivation Measure. The primary outcome was breast cancer-specific mortality. Secondary outcomes were stage at diagnosis and all-cause mortality. Cox regression models calculated adjusted hazard ratios (HR) and 95% confidence intervals (95% CIs) for mortality by house value category and deprivation, adjusting for confounders.

resultsAmong 12,766 women with breast cancer, women in the lowest versus highest house value category had a 60% increase in mortality (adjusted HR = 1.60 95% CI 1.34, 1.92; per 20 percentile decrease adjusted HR = 1.12 95% CI 1.08, 1.16) and were more likely diagnosed with stage 4 disease (7.5% versus 4.1%; P < 0.001). Women living in the most versus least deprived areas had a 26% increase in mortality (adjusted HR = 1.26 95% CI 1.08, 1.47; per 20 percentile decrease adjusted HR = 1.05 95% CI 1.01, 1.08) but had no difference in stage 4 disease (5.9% vs. 5.0%; P = 0.157).

conclusionIndividual-level house value demonstrated stronger associations with breast cancer outcomes than area-level deprivation, suggesting it may serve as a more sensitive indicator for monitoring health inequalities in cancer.

Indexed as

Breast NeoplasmsAdultAgedCohort StudiesFemaleHumansLow Socioeconomic StatusMiddle AgedNeoplasm StagingNorthern IrelandProportional Hazards ModelsRegistriesSocioeconomic Disparities in HealthSocioeconomic FactorsBreast cancerHouse valueProperty valueSocioeconomic positionStageSurvival

Identifiers

PMID41863581
PMCPMC13005866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.